免責聲明: 本站彙整 FDA、ClinicalTrials.gov、PubMed、SEC EDGAR 等官方公開資料,僅供一般參考,不構成醫療建議、診斷、治療建議或投資建議。

FDA 510(k)

Quo-Test A1c 系統

K 號:K180509 · 2019-02-16

決定日期2019-02-16
產品代碼LCP
諮詢委員會HE 請提供完整的描述文本,以便我能夠進行翻譯。
決定相當於

器材摘要

Quo-Test A1c System is the device name listed in this FDA 510(k) record. The listed applicant is Ekf-Diagnostic GmbH. It received FDA 510(k) clearance on 2019-02-16 under 510(k) number K180509. The device is classified under product code LCP. It was reviewed by the HE advisory panel. FDA Decision: Substantially Equivalent.

常見問題

What is the Quo-Test A1c System?

Quo-Test A1c System is a medical device that received FDA 510(k) clearance on 2019-02-16. The listed applicant is Ekf-Diagnostic GmbH. The 510(k) number is K180509.

When did Quo-Test A1c System receive FDA 510(k) clearance?

Quo-Test A1c System received FDA 510(k) clearance on 2019-02-16, under 510(k) number K180509.

Who is the listed applicant for Quo-Test A1c System?

The FDA 510(k) record lists Ekf-Diagnostic GmbH as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for Quo-Test A1c System?

The FDA product code for Quo-Test A1c System is LCP.

相關臨床試驗

相關紀錄係使用名稱、產品代碼或其他後設資料自動配對。配對結果並不構成已驗證的臨床、科學、企業或監管關係,請查閱連結的官方來源。

其他以 Ekf-Diagnostic GmbH 為申請人之記錄

相關紀錄係使用名稱、產品代碼或其他後設資料自動配對。配對結果並不構成已驗證的臨床、科學、企業或監管關係,請查閱連結的官方來源。

相關器械(代碼:LCP)

相關紀錄係使用名稱、產品代碼或其他後設資料自動配對。配對結果並不構成已驗證的臨床、科學、企業或監管關係,請查閱連結的官方來源。

官方來源

在 FDA 資料庫中查看 →

資料來源為 FDA Open API。如需最新且權威的資訊,請始終參閱官方記錄。

↑